John Chen, Ph.D
Chief Executive Officer & President
John Chen, Ph.D., founded BioCheck in January 1997 and is currently the President and CEO of BioCheck. In 1998 he was a cofounder of Rapid Diagnostics, Inc., a company that specialized in rapid test diagnostics for the detection of Drugs of Abuse. He served as a Director at Rapid Diagnostics until the company was acquired by ICN Pharmaceuticals in 2002. Prior to co-founding BioCheck, Dr. Chen co-founded Medix Biotech in 1983. Medix Biotech specialized in monoclonal/polyclonal antibodies, enzyme immunoassay test kits, and rapid test kits. Dr. Chen served as CEO of the company until Medix Biotech was fully acquired by Genzyme Corporation in 1992. Dr. Chen remained as VP of Research and Development of Medix until 1995. From 1981 to 1983, Dr. Chen co-founded Pacific Biotech where he was instrumental in the development of the first rapid pregnancy test. Pacific Biotech was acquired by Eli Lilly in 1990. He previously served research scientist roles at Sigma Chemical, Mallinckrodt, and Beckman Instruments. Dr. Chen holds a B.S. in Chemistry and a Ph.D. in Biochemistry.
Dr. Chen is a biochemist/clinical chemist with over 30 years of research and development experience. He has strong industry contacts and is renowned for his superior assay development capabilities. Over the years, he has developed more than 50 EIA and rapid tests in different formats, many of which have been approved for marketing by the FDA. His technical expertise in immunology and biochemistry is enhanced by his proven ability to facilitate technology transfer from research and development to manufacturing. His reputation of successfully managing the technical aspects of diagnostics has been instrumental in the creation of partnerships with other biotechnology and pharmaceutical companies.